HHHyeonsoo Han

Hyeonsoo Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hyeonsoo Han has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Structure-Based Virtual Screening and De Novo Design Guided by 3D-QSAR Triage for the Identification of Nanomolar STK3 Inhibitors

    by Ahyoung Jang, Kewon Kim, Hyeonsoo Han, Ye Eun Kim, Taeho Kim, Kee-Choo Chung, Sungwoo Hong, Hwangseo Park

    Serine/threonine kinase 3 (STK3) is a core kinase in the Hippo signaling pathway that regulates cell proliferation, differentiation, and apoptosis. Dysregulation of this pathway is linked to various cancers and immune disorders, emphasizing STK3 as a promising therapeutic target for diseases that involve abnormal cell growth. Despite their therapeutic relevance, only a limited number of potent STK3 inhibitors have been reported, likely due to the difficulty in designing molecules that can bind tightly to the ATP-binding site of STK3. Using the 2-(2-amino-5-phenylpyrimidin-4-yl)-5-methoxyphenol (APPP) scaffold identified through virtual screening, we discovered a series of novel, potent STK3 inhibitors with half-maximal inhibitory concentration (IC50) values as low as 3.52 nM. This was made possible through an integrated molecular design strategy that combined structure-based de novo design with a predictive 3D-QSAR model to estimate IC50 values and prioritize compounds for synthesis. This approach improved the prioritization of compounds for synthesis by enhancing binding energy discrimination beyond the limitations of scoring functions in de novo design. Strategic derivatization at four defined positions on the APPP core enhanced interactions in the ATP-binding site of STK3, resulting in 18 of the 25 synthesized derivatives exhibiting IC50 values below 100 nM. These findings are particularly significant given the scarcity of known STK3 inhibitors with comparable potency, while also indicating that 3D-QSAR modeling contributed as a complementary triage tool rather than a standalone driver of lead discovery. This advancement stems from the use of quantum-mechanically derived 3D structural alignments and the incorporation of electrostatic potential distributions as quantitative molecular descriptors. Taken together, this study establishes a robust design paradigm for the rapid development of highly potent kinase inhibitors through structure-based computational strategies.

  • Divergent Pyridine-to-Pyrazole Conversion via Carbon-Retentive Skeletal Editing

    by Hyeonsoo Han, Xiangzhang Tao, Heeho Noh, Jinwook Jeong, Changyoung Jung, Jiyong Park, Sungwoo Hong

    Regioselective pyrazole synthesis remains a longstanding challenge in medicinal chemistry due to difficulties controlling N-differentiation during ring construction or functionalization. We address this through carbon-retentive skeletal editing that preserves molecular complexity while encoding regioselectivity during framework reorganization. From a single pyridine, mechanistically divergent pathways deliver structurally distinct pyrazoles: photochemical radical deconstruction-rearrangement yields aldehyde- or amine-substituted products; thermal polar reorganization with hydrazines provides orthogonal substitution patterns. Both proceed under mild, one-pot conditions and accommodate complex pharmaceuticals. This divergent platform enables predictable access to complementary pyrazole architectures from common pyridines, circumventing the regioselectivity limitations of peripheral functionalization and expanding accessible chemical space for drug discovery.


  • Transformation of Pyridines into 2D and 3D Fused Bicyclic Heterocycles

    by Xiangzhang Tao, Hyeonsoo Han, Jinwook Jeong, Dongwook Kim, Sungwoo Hong

    Skeletal editing of heteroarenes in complex molecules represents a transformative synthetic strategy that transcends the limitations of conventional peripheral functionalization, enabling the profound structural diversification of molecular frameworks. Here, we demonstrate a powerful metal-free approach for converting pyridines into planar (2D) and three-dimensional (3D) fused bicyclic heterocycles through a precisely orchestrated process of nucleophilic addition, 6π-electrocyclic ring opening/ring closure, and fused ring formation. This methodology exploits the unique reactivity of N-pyridinium salts with hydrazine nucleophiles, accommodating diverse functional groups in a sequential one-pot protocol. In addition, a modified procedure enabled the synthesis of C3-brominated heterocyclic scaffolds. The synthetic utility is further demonstrated by successful late-stage modifications of structurally complex bioactive molecules. Comprehensive mechanistic investigations, including the isolation of key intermediates and computational studies, offer critical insights into the reaction pathway. Our findings establish a versatile platform for the strategic reconstruction of pyridine cores, significantly expanding the accessible chemical space. Notably, the newly synthesized pyrazolopyridazine scaffolds exhibit low-micromolar inhibitory activity over JNK1, positioning them as promising candidates with a substantial medicinal chemistry value for further optimization. This bioactivity validation underscores how our findings establish a versatile platform for the strategic reconstruction of pyridine cores, considerably expanding the accessible chemical space for drug discovery.